The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $42.24

Today's change-0.11 -0.26%
Updated May 5 9:32 AM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $42.24

Today's change-0.11 -0.26%
Updated May 5 9:32 AM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC down (U.S.)$0.11

GlaxoSmithKline PLC is lower today, dropping (U.S.)$0.11 or 0.26% to (U.S.)$42.24. Shares have lost 2.59% over the last five days, but have gained 4.68% over the last year to date. This security has underperformed the S&P 500 by 5.78% during the last year.

Key company metrics

  • Open(U.S.) $42.21
  • Previous close(U.S.) $42.35
  • High(U.S.) $42.24
  • Low(U.S.) $42.14
  • Bid / Ask(U.S.) $42.22 / (U.S.) $42.23
  • YTD % change+4.68%
  • Volume113,785
  • Average volume (10-day)3,145,282
  • Average volume (1-month)3,366,334
  • Average volume (3-month)3,717,510
  • 52-week range(U.S.) $37.24 to (U.S.) $46.76
  • Beta0.80
  • Trailing P/E8.32×
  • P/E 1 year forward16.74×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.34
  • Dividend yield5.53%
  • Trailing EPS(U.S.) $5.07
Updated May 5 9:32 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6,2866,1275,8885,622
Total other revenue--------
Total revenue6,2866,1275,8885,622
Gross profit4,0824,0613,9933,745
Total cost of revenue2,2042,0661,8951,877
Total operating expense6,5395,1045,552-4,437
Selling / general / administrative2,1221,9142,1411,951
Research & development846730731789
Depreciation / amortization109913
Interest expense (income), net operating--------
Unusual expense (income)910282838-8,990
Other operating expenses, total447103-62-77
Operating income-2531,02333610,059
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4168671529,923
Income after tax-4286471158,038
Income tax, total12220371,885
Net income-3545381498,089
Total adjustments to net income--------
Net income before extra. items-3545381498,089
Minority interest74-1093451
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3545381498,089
Inc. avail. to common incl. extra. items-3545381498,089
Diluted net income-3545381498,089
Dilution adjustment00----
Diluted weighted average shares4,8374,8774,8744,820
Diluted EPS excluding extraordinary itemsvalue per share-0.070.110.031.68
Dividends per sharevalue per share0.230.190.190.19
Diluted normalized EPSvalue per share0.050.150.160.17